This content requires Flash Player 8 or higher.Please download it here
insert therapeutics unidym tego bio sciences science research anti-cancer drugs RNAi therapeutics carbon-based electronics nanotechnology arrowhead pasadena california nasdaq arwr
nanotechnology arrowhead pasadena california nasdaq arwr nanotechnology arrowhead pasadena california nasdaq arwr nanotechnology arrowhead pasadena california nasdaq arwr compound semiconductor materials nano particles laboratory

Arrowhead Research Corporation is a nanotechnology holding company that seeks to monetize disruptive technologies through its majority-owned subsidiaries. We create these subsidiaries around university-derived technologies as well as through rolling up existing companies.

Both strategies, often used together for a single subsidiary, spring from the efficiency of leverage. Building companies around university-developed technology leverages government-funded research and deep scientific expertise, while rolling up companies to create a single entity leverages capital investments and product development time that precede Arrowhead’s involvement.

Arrowhead is highly active in the operation of its subsidiaries, providing initial management, operational support, business development and financing.

Read more

Click here to Join the Webcast

Event: Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call

Date: Monday, December 15, 2008

Time: 5:00 PM ET (2:00 PM PT)

Duration: 1 hour


News & Press Releases

News archive >

Unique Value Proposition

Upside potential of a
disruptive technology pure-play

Diversification of a portfolio

Capital efficiency of a
holding company structure

Our Business Model

university academic intellectual property sponsored research



Larger view

shareholders press release news investor relations r. bruce stewart
arrowhead research nanotechnology scientific research pasadena los angeles california
ecommerce flash video design web site html designers los angeles pasadena